Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial.
Takahashi K, Otsuki H, Zimmermann FM, Ding VY, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B, Fearon WF; FAME 3 Trial Investigators. Takahashi K, et al. Among authors: yeung ac. JACC Cardiovasc Interv. 2024 Nov 11:S1936-8798(24)01217-2. doi: 10.1016/j.jcin.2024.09.030. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 39641725
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy.
Otsuki H, Takahashi K, Zimmermann FM, Mavromatis K, Aminian A, Jagic N, Dambrink JE, Kala P, MacCarthy P, Witt N, Kobayashi Y, Takahashi T, Woo YJ, Yeung AC, De Bruyne B, Pijls NHJ, Fearon WF; FAME 3 Trial Investigators. Otsuki H, et al. Among authors: yeung ac. Circ Cardiovasc Interv. 2024 Nov;17(11):e014300. doi: 10.1161/CIRCINTERVENTIONS.124.014300. Epub 2024 Nov 6. Circ Cardiovasc Interv. 2024. PMID: 39502029 Clinical Trial.
Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach: FAME 3 Trial.
Dawson LP, Kobayashi Y, Zimmermann FM, Takahashi T, Wong CC, Theriault-Lauzier P, Pijls NHJ, De Bruyne B, Yeung AC, Woo YJ, Fearon WF; FAME 3 Trial Investigators. Dawson LP, et al. Among authors: yeung ac. JACC Cardiovasc Interv. 2024 Aug 26;17(16):1861-1871. doi: 10.1016/j.jcin.2024.06.003. JACC Cardiovasc Interv. 2024. PMID: 39197985 Clinical Trial.
Sex-Specific Disparities in Clinical Outcomes After Transcatheter Aortic Valve Replacement Among Different Racial Populations.
Kim M, Kang DY, Ahn JM, Kim JB, Yeung AC, Nishi T, Fearon WF, Cantey EP, Flaherty JD, Davidson CJ, Malaisrie SC, Kim HJ, Lee J, Park J, Kim H, Cho S, Choi Y, Park SJ, Park DW. Kim M, et al. Among authors: yeung ac. JACC Asia. 2024 Feb 13;4(4):292-302. doi: 10.1016/j.jacasi.2023.11.016. eCollection 2024 Apr. JACC Asia. 2024. PMID: 38660112 Free PMC article.
Luteal phase support in assisted reproductive technology.
Garg A, Zielinska AP, Yeung AC, Abdelmalak R, Chen R, Hossain A, Israni A, Nelson SM, Babwah AV, Dhillo WS, Abbara A. Garg A, et al. Among authors: yeung ac. Nat Rev Endocrinol. 2024 Mar;20(3):149-167. doi: 10.1038/s41574-023-00921-5. Epub 2023 Dec 18. Nat Rev Endocrinol. 2024. PMID: 38110672 Review.
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial.
Kobayashi Y, Takahashi T, Zimmermann FM, Otsuki H, El Farissi M, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, De Bruyne B, Pijls NHJ, Fearon WF; FAME 3 Trial Investigators. Kobayashi Y, et al. Among authors: yeung ac. JACC Cardiovasc Interv. 2023 Sep 11;16(17):2112-2119. doi: 10.1016/j.jcin.2023.06.023. JACC Cardiovasc Interv. 2023. PMID: 37704297 Free article. Clinical Trial.
323 results